XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash $ 977,208 $ 819,024
Accounts receivable, net 1,538,941 2,057,546
Inventories, net 6,382,209 6,936,980
Prepaid and other current assets 452,762 548,561
Note receivable 185,000
Total current assets 9,351,120 10,547,111
Property and equipment, net 597,382 799,892
Right-of-use assets 2,916,300 3,525,406
Intangible assets, net 2,312,333 2,615,281
Goodwill 7,402,644 7,402,644
Other assets 251,057 265,567
Total assets 22,830,836 25,155,901
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable 3,145,128 3,062,794
Accrued liabilities 1,663,941 1,944,352
Convertible note 4,264,541 4,504,500
Other short-term loan 1,122,000
Contract liabilities 779,993 226,316
Current portion of lease liabilities 892,172 901,925
Current portion of COVID loan 293,158 391,545
Total current liabilities 12,160,933 11,031,432
Long-term portion of lease liabilities 2,119,690 2,721,743
Long-term portion of COVID loan 321,014 489,037
Defined benefit plan obligation 154,725 216,133
Total liabilities 14,756,362 14,458,345
COMMITMENTS AND CONTINGENCIES (NOTE 10)
STOCKHOLDERS’ EQUITY:    
Preferred Stock, $0.001 par value, 25,000,000 shares authorized: Preferred Stock, Series F Convertible, $0.001 par value, 35,000 shares authorized, 4,295 shares issued and outstanding as of June 30, 2024, and 6,075 shares issued and outstanding as of December 31, 2023 4 6
Common Stock, $0.001 par value, 250,000,000 shares authorized, 13,838,705 and 7,026,297 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 13,840 7,026
Additional paid-in capital 188,192,663 176,167,312
Accumulated deficit (180,085,841) (165,583,091)
Accumulated other comprehensive (loss) income (46,192) 106,303
Total stockholders’ equity 8,074,474 10,697,556
Total liabilities and stockholders’ equity $ 22,830,836 $ 25,155,901